Alembic Limited (BOM:506235)
India · Delayed Price · Currency is INR 91.22
+1.70 (1.90%)
At close: Jul 31, 2026
Alembic Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 2,400 | 2,400 | 2,219 | 1,575 | 1,272 | 782.18 |
Revenue Growth | 8.16% | 8.16% | 40.89% | 23.77% | 62.68% | 6.40% |
Gross Profit Gross Profit Growth | 1,551 | 1,551 | 1,429 | 1,000 | 809.9 | 496.07 |
Operating Income Operating Income Growth | 777.12 | 777.12 | 830.79 | 490.22 | 336.09 | 90.67 |
Net Income Net Income Growth | 3,174 | 3,174 | 3,107 | 2,686 | 1,906 | 2,221 |
Earnings Per Share EPS Growth | 12.36 | 12.36 | 12.10 | 10.46 | 7.42 | 8.65 |
EPS Growth | 2.16% | 2.16% | 15.66% | 40.90% | -14.14% | -35.23% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Active Pharmaceutical Ingredient (API) Active Pharmaceutical Ingredient (API) Growth | 465.85 | 465.85 | 322.15 | 317.42 | 264.88 | 322.66 |
Real Estate Real Estate Growth | 1,934 | 1,934 | 1,897 | 1,257 | 1,008 | 459.51 |
Total Total Growth | 2,400 | 2,400 | 2,219 | 1,575 | 1,272 | 782.18 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 980.38 | 980.38 | 582.7 | 128.57 | 463.55 | 270.43 |
Total Debt Total Debt Growth | 106.39 | 106.39 | 144.47 | 91.49 | - | - |
Net Cash (Debt) Net Cash Growth | 874 | 874 | 438.23 | 37.08 | 463.55 | 270.43 |
Net Cash Growth | 99.44% | 99.44% | 1081.85% | -92.00% | 71.41% | 21.69% |
Net Cash Per Share Net Cash Per Share Growth | 3.40 | 3.40 | 1.71 | 0.14 | 1.81 | 1.05 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,201 | 1,201 | 863.7 | 226.87 | 388.53 | -177.47 |
Capital Expenditures CapEx Growth | -766.51 | -766.51 | -507.66 | -562.9 | -258.18 | -358.13 |
Free Cash Flow Free Cash Flow Growth | 434.14 | 434.14 | 356.05 | -336.03 | 130.35 | -535.6 |
Free Cash Flow Growth | 21.93% | 21.93% | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 64.62% | 64.62% | 64.39% | 63.51% | 63.65% | 63.42% |
Operating Margin | 32.38% | 32.38% | 37.44% | 31.13% | 26.41% | 11.59% |
Pretax Margin | 141.76% | 141.76% | 144.94% | 176.80% | 154.69% | 298.81% |
Profit Margin | 132.25% | 132.25% | 140.02% | 170.57% | 149.83% | 283.90% |
FCF Margin | 18.09% | 18.09% | 16.05% | -21.34% | 10.24% | -68.48% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.400 | 2.400 | 2.400 | 2.400 | 2.200 | 1.800 |
Dividend Per Share Growth | 0% | 0% | 0% | 9.09% | 22.22% | 800.00% |
Dividend Yield | 2.63% | 3.38% | 2.49% | 2.98% | 3.96% | 2.72% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 7.38 | 5.74 | 8.14 | 8.00 | 7.99 | 8.37 |
P/FCF Ratio | 53.95 | 41.94 | 71.03 | - | 116.80 | - |
PS Ratio | 9.76 | 7.59 | 11.40 | 13.64 | 11.97 | 23.75 |